Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Struggling Orthovita Taps Distributors To Chase Outpatient Vertebroplasties

This article was originally published in The Gray Sheet

Executive Summary

A rapid shift of minimally invasive procedures for vertebrae fractures to the outpatient setting is weighing down Orthovita's growth prospects, but the firm says it plans to leverage external distributors to counteract some of the pressure

You may also be interested in...



Stryker Bets $316 Million It Can Invigorate Orthovita's Biologics Biz

Stryker hopes its sales force heft can push Orthovita's line of synthetic orthobiologics into a better growth position while filling important competitive gaps.

Stryker Bets $316 Million It Can Invigorate Orthovita's Biologics Biz

Stryker hopes its sales force heft can push Orthovita's line of synthetic orthobiologics into a better growth position while filling important competitive gaps.

Vertebroplasty Shows No More Benefit Than Sham Procedures In Trials

The first two blinded, randomized, placebo-controlled trials of vertebroplasty treatment for spinal fractures suggest that the procedure may have no lasting benefit, researchers report in the Aug. 6 New England Journal of Medicine

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT029240

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel